Nonviral gene therapy in vivo with PAM-RG4/apoptin as a potential brain tumor therapeutic
Songhie An,* Kihoon Nam,* Sunghyun Choi, Cheng Z Bai, Yan Lee, Jong-Sang ParkDepartment of Chemistry, Seoul National University, Seoul, Republic of Korea*These authors contributed equally to this workBackground: Glioma is still one of the most complicated forms of brain tumor to remove completely du...
Guardado en:
Autores principales: | An S, Nam K, Choi S, Bai CZ, Lee Y, Park JS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e42b4347afa45838f688e99e98815de |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
λ Phage nanobioparticle expressing apoptin efficiently suppress human breast carcinoma tumor growth in vivo.
por: Alireza Shoae-Hassani, et al.
Publicado: (2013) -
Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tetsu Tomonari, et al.
Publicado: (2021) -
Targeted nonviral gene therapy in prostate cancer
por: Altwaijry N, et al.
Publicado: (2018) -
Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul A, et al.
Publicado: (2019) -
Research progress on siRNA delivery with nonviral carriers
por: Gao Y, et al.
Publicado: (2011)